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Symptomatic AF but no silent AF is associated with an increased
occurrence of ventricular arrhythmias after acute myocardial infarc-
tion
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Objectives: The aims of our study were to assess ventricular tachycardia
or fibrillation (VT or VF) occurrence after AMI and to analyse the relationship
with either symptomatic or silent AF occurrence.
Background: Silent or symptomatic AF are known to be common after
AMI and to impair patients prognosis. But the reasons of this worse prognosis
remain discussed.
Methods: 849 consecutive AMI were prospectively analyzed by contin-
uous ECG monitoring (CEM) during the first 48 hours after admission. All
AF, VT or VF episodes were confirm by standard ECG and sytematically
reviewed by two investigators. The population was studied into three groups:
No AF, Silent AF, and symptomatic AF after AMI. 
Results: Forty five patients (5%) developed symptomatic AF and one hun-
dred and thirty five developed silent AF (15.9%). Compared with the no AF
group, patients with AF were markedly older 80 (67-85) and 81(71-88) vs. 62
(53-75) years; with p<0.001), more likely to have hypertension (96(72%) and
(35(80%) vs 332(50%); with p<0.001) and less smoker (26 (20%) and 3(7%)
vs. 242 (36%); with p<0.001). Comparing these three groups at day 1 and day
2, patients with symptomatic AF had higher heart rate (maximum, median or
minimum) than patients with silent or no AF. Thus, at day 1 there was trend
to a higher rate of VT or VF occurrence in symptomatic AF group, that was
confirm at day 2 with 11(24.4%) vs 7(5.2%) in silent AF group and 29(4.3%)
in no AF group, with p<0.001. Moreover, in-hospital mortality was higher in
symptomatic AF group (8 (17.8%)) than in silent AF group (14 (10.4%)) and
in no AF group (9 (1.3%)) with p<0.001.
Conclusion: Symptomatic AF is very common after AMI and impacts
patient’s outcome with more frequent episodes of VT or VF and higher in-
hospital mortality (17.8%). Our large prospective study suggests that VT or
VF occurrence associated with symptomatic AF could be linked with the
higher mortality in this population.
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Use of 2nd generation cryoballoon with reduced dosing strategy is
superior to 1st generation cryoballoon for paroxysmal atrial fibrilla-
tion ablation
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Background: With the technical properties of the 2nd generation (Arctic
Front Advance, AFA) cryoballoon (CB), we postulated we could reduce
complication rate without impairing efficacy in the treatment of paroxysmal
atrial fibrillation if we stop the bonus application.
Method: Since January 2011, all patients referred to our institution for
ablation of symptomatic drug refractory paroxysmal atrial fibrillation were
included (n=129). Until June 2012, the ablation was performed with the Arctic
Front cryoballoon (AF-CB) with application of 4mm bonus freeze after PVI
(n=47). From July 2012 to December 2013, the ablation procedure was per-
formed with the AFA-CB, without bonus freeze after PVI in 82 patients. All
patients were seen at 4 to 6 month follow-up. They underwent at least 1 Holter
monitoring in the post-operative period (2-4 month after ablation). Mid-term
clinical success was defined by the association of sinus rhythm on ECG and
Holter monitoring and lack of symptoms.
Results: Compared to the AFCB group, there was a significant reduction
of the procedure time (131 min vs 95 min; p < 0.01), the X-ray exposure
(27Gy/cm² vs 20 Gy/cm²; p = 0.04) in the AFACB group. Isolation of the
4 PVs was obtained in 89 and 96% (p = 0.24) before performing a touch up
with a Freezor Max catheter in the AFCB and AFACB group respectively.
Using our definition for success, the mid-term success rate was higher in
the AFA-CB group as compared with that of in the AF-CB group (78% vs
53% p = 0.01; CI [1,3 – 6,5]).
Significant complications occurred in 9% in the AFA-CB group versus
13% in the AF-CB group (p = 0.44). There was no difference regarding the
rate of phrenic nerve palsy (7% AF-CB group vs 5% AFA-CB group;
p=0.24).
Conclusion: The lack of a bonus freeze application after PVI allows to
significantly reducing the procedure time and the X-ray exposure. Even when
using a reduced dosing strategy, our study shows the AFA-CB leads to a
better outcome as compared to the AF-CB. 
0126
Evolution of early repolarization patterns after 5 years in a military
population at low cardiovascular risk and practical implications in
military medical expertise
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Aim: The French military population is a young and athletic population
with a high prevalence of early repolarization patterns (ERP) compared to the
general population. Screening of military officers at risk of sudden death (SD)
is a priority in military medical expertise. The aim of our study was to eva-
luate the prevalence of ERP and its evolution over a period of 5 years in a
specific asymptomatic population, free of heart disease and cardiovascular risk
factors. 
Methods: From March to December 2008, we prospectively collected the
ECGs of military officers enlisted into the submarine forces of France. For
5 years (until 2012), the military officers included in the study underwent a
clinical examination twice per year. A new ECG was carried out 5 years after
the initial one.
Results: 250 male subjects were included (mean age 22.87±0.5 years). The
prevalence of ERP was 19.2%. The most common appearance was an eleva-
tion of a slurring type J point (31/48 or 64.5%) in inferolateral leads (18/48 or
37.8%). After 5 years, the prevalence of ERP was identical to that of the
previous period (19.2%) with no change in appearance, distribution and
amplitude in 47 subjects (97.9%). Repolarization changed in 2 patients
(1 occurrence of ERP and 1 disappearance). During the 5 years of follow-up,
the subjects remained asymptomatic
Conclusion: ERP is common in our population of young, athletic and
asymptomatic military officers and changes little in 5 years
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